302 related articles for article (PubMed ID: 28158151)
1. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
[TBL] [Abstract][Full Text] [Related]
2. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
4. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
[TBL] [Abstract][Full Text] [Related]
5. Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin.
Viel E; Eerdekens M; Kandaswamy P
Pain Physician; 2021 Sep; 24(6):453-463. PubMed ID: 34554688
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.
Simpson DM; Robinson-Papp J; Van J; Stoker M; Jacobs H; Snijder RJ; Schregardus DS; Long SK; Lambourg B; Katz N
J Pain; 2017 Jan; 18(1):42-53. PubMed ID: 27746370
[TBL] [Abstract][Full Text] [Related]
7. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Goncalves D; Rebelo V; Barbosa P; Gomes A
Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
[TBL] [Abstract][Full Text] [Related]
8. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Maihofner C; Heskamp ML
Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK
Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442
[TBL] [Abstract][Full Text] [Related]
11. Use of High-Concentration Capsaicin Patch for the Treatment of Pelvic Pain: Observational Study of 60 Inpatients.
Levesque A; Riant T; Labat JJ; Ploteau S
Pain Physician; 2017; 20(1):E161-E167. PubMed ID: 28072808
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Burness CB; McCormack PL
Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
[TBL] [Abstract][Full Text] [Related]
13. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Hansson P; Jensen TS; Kvarstein G; Strömberg M
Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
[TBL] [Abstract][Full Text] [Related]
14. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Simpson DM; Brown S; Tobias JK; Vanhove GF;
Clin J Pain; 2014 Feb; 30(2):134-42. PubMed ID: 23446088
[TBL] [Abstract][Full Text] [Related]
15. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
[TBL] [Abstract][Full Text] [Related]
16. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
Ellison N; Loprinzi CL; Kugler J; Hatfield AK; Miser A; Sloan JA; Wender DB; Rowland KM; Molina R; Cascino TL; Vukov AM; Dhaliwal HS; Ghosh C
J Clin Oncol; 1997 Aug; 15(8):2974-80. PubMed ID: 9256142
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
Soin A; Bock G; Giordano A; Patel C; Drachman D
Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain.
Raber JM; Reichelt D; Grüneberg-Oelker U; Philipp K; Stubbe-Dräger B; Husstedt IW
Acta Neurol Belg; 2015 Sep; 115(3):335-43. PubMed ID: 25421590
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
[TBL] [Abstract][Full Text] [Related]
20. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Aitken E; McColl G; Kingsmore D
Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
